Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02988609
Other study ID # RC31/15/7730
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date September 2016
Est. completion date October 10, 2022

Study information

Verified date January 2024
Source University Hospital, Toulouse
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study assess the putative persistence of neural damage using resting state fMRI after concussion in rugby player once they have clinically recovered. The hypothesis is that despite a clinical recovery (absence of symptoms; neurological and neuropsychological examination returned to normal) connectivity map obtained using resting state fMRI are significantly different from a group of control subjects.


Description:

Resting state fMRI has shown to be a sensitive tool to assess neural damage after concussion. It seems more sensible than structural MRI including DTI. the study goal will be to assess rugby players using fMRI at 3 different times after concussion: just after concussion (V1), once players have clinically recovered (V2) and 3 months after V2 (V3). The study would specifically like to challenge clinical examination supposed to be normal at V2 to connectivity maps using resting state fMRI preformed at the same time. fMRI performed at V1 and V3 will serve as comparators (respectively very altered at V1 and back to normal at V3).


Recruitment information / eligibility

Status Terminated
Enrollment 44
Est. completion date October 10, 2022
Est. primary completion date August 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - no neurological or psychiatric disease - recent history of concussion (<3 months) according to the Rugby French Federation criteria. Exclusion Criteria: - Inability to be assessed by MRI

Study Design


Related Conditions & MeSH terms


Intervention

Device:
fMRI
fMRI at 3 different times after concussion: just after concussion (V1), once players have clinically recovered (V2) and 3 months after V2 (V3).

Locations

Country Name City State
France University Hospital Toulouse

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Toulouse

Country where clinical trial is conducted

France, 

References & Publications (1)

Smits M, Houston GC, Dippel DW, Wielopolski PA, Vernooij MW, Koudstaal PJ, Hunink MG, van der Lugt A. Microstructural brain injury in post-concussion syndrome after minor head injury. Neuroradiology. 2011 Aug;53(8):553-63. doi: 10.1007/s00234-010-0774-6. Epub 2010 Oct 6. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Difference of connectivity maps between the players with concussion and the group control connectivity maps obtained during a 10 minutes resting state fMRI at V2 up to 1 month
Secondary Difference of connectivity maps between the players with concussion and the group control Connectivity maps obtained during a 10 minutes resting state fMRI at V1 and V3 up to 3 months
Secondary neuropsychological questionnaire Scores obtained the neuropsychological assessment. Memory, attention and executive functions will be assessed using validated tools. up to 3 months
Secondary neurophysiological data Structural imaging data (DTI) up to 3 months
See also
  Status Clinical Trial Phase
Completed NCT03304327 - Mindfulness and Yoga Training for Athletes With Concussion (MYTAC) N/A
Completed NCT05562544 - EEG Diagnostic for Repetitive Sub-concussive Head Impacts
Completed NCT02710123 - Sub-Threshold Exercise Treatment for Adolescents With Sports Related Concussion N/A
Terminated NCT02100150 - A Safety and Efficacy Study of NNZ-2566 in Patients With Mild Traumatic Brain Injury (mTBI) Phase 2
Active, not recruiting NCT01874847 - PLAY GAME: Post-concussion Syndrome in Youth - Assessing the GABAergic Effects of Melatonin Phase 2/Phase 3
Completed NCT02262507 - Concussion Device Audiological Measures N/A
Completed NCT01903525 - DHA For The Treatment of Pediatric Concussion Related to Sports Injury Phase 1
Enrolling by invitation NCT05948501 - The Effects of Concussion on Gait and Posture in Individuals With Peripheral Vision Loss
Withdrawn NCT02643836 - Pulsed Electromagnetic Field (PEMF) Therapy for Post-Concussive Syndrome N/A
Recruiting NCT03360786 - Primary Prevention of Concussion in Youth Ice Hockey Players N/A
Recruiting NCT03710109 - Evaluation of an EEG Based Concussion System
Not yet recruiting NCT02930395 - Blood Biomarkers for the Management of Concussion in Professional Rugby Players N/A
Completed NCT02278029 - Driving Performance of Teenage Patients With mTBI: a Longitudinal Assessment N/A
Completed NCT02271451 - Q-collar and Brain Injury Biomarkers N/A
Completed NCT02268240 - Care for Post-Concussive Symptoms N/A
Completed NCT02268058 - Use of Ibuprofen and Acetaminophen for Treatment of Acute Headache Post Concussion in Children N/A
Active, not recruiting NCT03608722 - Video Games to Track Cognitive Health N/A
Completed NCT02556177 - Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2 N/A
Completed NCT02660164 - A Study to Assess the Effectiveness of the Nautilus BrainPulseâ„¢ as an Aid in the Diagnosis of Concussion
Completed NCT02344446 - Physical Therapy Intervention for Extended Physical Symptoms After a Sports-related Concussion N/A